These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38733528)

  • 1. Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis.
    Avrahami M; Liwinski T; Eckstein Z; Peskin M; Perlman P; Sarlon J; Lang UE; Amital D; Weizman A
    Psychopharmacology (Berl); 2024 Sep; 241(9):1883-1894. PubMed ID: 38733528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric Disorders.
    Remmerie B; Ariyawansa J; De Meulder M; Coppola D; Berwaerts J
    J Clin Pharmacol; 2016 Jun; 56(6):683-92. PubMed ID: 26412032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.
    Smith RL; Haslemo T; Refsum H; Molden E
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1099-104. PubMed ID: 27353638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of dosage of sustained-release formulation on valproate clearance and plasma concentration in psychiatric patients: analysis based on routine therapeutic drug monitoring data.
    Sriboonruang T; Panomvana D; Chamchitchun S; Silpakit O
    J Clin Psychopharmacol; 2011 Feb; 31(1):115-9. PubMed ID: 21192154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism.
    Smith RL; Kyllesø L; Haslemo T; Andreassen OA; Molden E
    Ther Drug Monit; 2019 Aug; 41(4):503-508. PubMed ID: 31259880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.
    Rakic Ignjatovic A; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M
    Br J Clin Pharmacol; 2009 Feb; 67(2):199-208. PubMed ID: 19076986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term valproic acid treatment on hematological and biochemical parameters in adolescent psychiatric inpatients: a retrospective naturalistic study.
    Amitai M; Sachs E; Zivony A; Remez R; Ben Baruch R; Amit BH; Kronenberg S; Apter A; Shoval G; Weizman A; Zalsman G
    Int Clin Psychopharmacol; 2015 Sep; 30(5):241-8. PubMed ID: 26020713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety range of free valproic acid serum concentration in adult patients.
    Tseng YJ; Huang SY; Kuo CH; Wang CY; Wang KC; Wu CC
    PLoS One; 2020; 15(9):e0238201. PubMed ID: 32877431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?
    Cuomo A; Barillà G; Cattolico M; Carmellini P; Spiti A; Pozza A; Fagiolini A
    Bipolar Disord; 2024 May; 26(3):277-283. PubMed ID: 37957926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet.
    Garikipati V; Toops DS; Fang Q
    Curr Med Res Opin; 2008 Jul; 24(7):1869-76. PubMed ID: 18593524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Valproic Acid on Olanzapine Serum Concentration: A Study Including 2791 Patients Treated With Olanzapine Tablets or Long-Acting Injections.
    Tveito M; Smith RL; Høiseth G; Molden E
    J Clin Psychopharmacol; 2019; 39(6):561-566. PubMed ID: 31688390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients.
    Cuturic M; Abramson RK; Moran RR; Hardin JW; Hall AV
    World J Biol Psychiatry; 2011 Feb; 12(1):73-9. PubMed ID: 20586533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients.
    Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Xiao J; Chen XP
    J Clin Pharm Ther; 2017 Apr; 42(2):221-227. PubMed ID: 28145574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of response to valproate in geriatric inpatients.
    Niedermier JA; Nasrallah HA
    Ann Clin Psychiatry; 1998 Dec; 10(4):165-8. PubMed ID: 9988057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
    Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
    Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
    Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ
    Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.